𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor necrosis factor as an antineoplastic agent: pitfalls and promises

✍ Scribed by H. Mueller

Book ID
105759817
Publisher
Springer
Year
1998
Tongue
English
Weight
139 KB
Volume
54
Category
Article
ISSN
1420-682X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B cell depletion may be more effective t
B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents
✍ Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt

Pigment epithelium-derived factor as an
Pigment epithelium-derived factor as an impending therapeutic agent against vascular epithelial growth factor-driven tumor-angiogenesis
✍ Katrina B. Manalo; Peter F.M. Choong; Crispin R. Dass 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

In spite of the recent epidemiological study indicating a positive decrease in cancer trends, cancer remains to be one of the major causes of deaths and there is an anticipated increase in the number of new cancer cases to be recorded in the following years to come. It is important for researchers t